Fetal Brain Asymmetry: in Utero and Early Neonatal Follow up

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2012 by HaEmek Medical Center, Israel.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier:
NCT01707875
First received: October 14, 2012
Last updated: October 15, 2012
Last verified: July 2012
  Purpose

Fetal brain asymmetry is considered a normal developmental processes. The size and shape of the lateral ventricles are interdependence with the brain parenchyma. Abnormal development of the fetal brain may cause unilateral or bilateral ventriculomegaly. Fetal cerebral ventricle measurement is one of the most frequently used sonographic tool for the evaluation of brain development. It is easier to evaluate and measure the distal cerebral ventricle, and therefore data concerning the normal range of asymmetry and the normal progress of the asymmetry are limited.

The objective of the study is to follow up the incidental finding of fetal ventricle brain asymmetry between 19-30 weeks of pregnancy.


Condition Intervention
Fetal Ventricle Brain Asymmetry
Other: fetal brain neurosonography

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective

Further study details as provided by HaEmek Medical Center, Israel:

Estimated Enrollment: 417
Study Start Date: November 2012
Groups/Cohorts Assigned Interventions
fetal ventricle brain asymmetry Other: fetal brain neurosonography
fetal brain neurosonography according to the ISUG guidelines

  Eligibility

Ages Eligible for Study:   18 Years to 42 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Pregnant women with fetal ventricle brain asymmetry

Criteria

Inclusion Criteria:

  • 18-42 years old pregnant women
  • 19-30 weeks of pregnancy
  • No medical history of chronic disease
  • No medical history of drug therapy
  • No other findings on ultrasound examination
  • Low risk pregnancy

Exclusion Criteria:

  • Fetal malformation
  • Chronic maternal disease
  • Fetal chromosomal aberration
  • suspected fetal infection
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier: NCT01707875     History of Changes
Other Study ID Numbers: EMC-0062-12-CTIL
Study First Received: October 14, 2012
Last Updated: October 15, 2012
Health Authority: Israel: Ministry of Health

ClinicalTrials.gov processed this record on August 28, 2014